Soaring US demand and high drug prices may be keeping the weight loss injections from other nations
Drugmaker Novo Nordisk is struggling to keep up with demand for its weight loss treatment Wegovy, and high prices in the US may explain why it has yet to launch more widelyThe weight loss injection Wegovy was launched in the US in 2021 but remains unavailable in most other countriesThe weight loss injection Wegovy is one of the most successful new pharmaceuticals, but many people who want it can’t actually access it.
In most countries in Europe, Wegovy hasn’t yet been launched, despite expected high demand. In the US, one of the few places where it is available, manufacturer Novo Nordisk has been trying to limit the number of people who start taking the medicine.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Wegovy reimbursement would cost Denmark up to $4 billion each year, ministry reportsThe Danish government could face an annual expenditure of up to $4 billion if it decides to reimburse Novo Nordisk's weight-loss drug, Wegovy, for nearly 900,000 individuals.
Leer más »
What we still don’t know about Wegovy’s effect on strokes and heart attacksA clinical trial suggests that semaglutide, a drug used to treat obesity and diabetes, may protect cardiovascular health in a broad group of people.
Leer más »
Semaglutide used for weight loss also helps reduce heart failure symptoms, study findsSemaglutide is found in drugs including Ozempic and Wegovy.
Leer más »
Why Christopher Nolan Didn't Want To Cast Joey Pantoliano In Memento (& Why He Was Perfect)Joe Pantoliano almost missed out on Memento
Leer más »
SLO County’s unfunded pension liability soaring, nearly $1 billionBy KAREN VELIE San Luis Obispo County’s unfunded pension liability is almost $1 billion, primarily because of huge pay raises and poorly performing investments. The SLO County Pension Trust Board o…
Leer más »